Krystal Biotech Income Statement (2021-2025) | KRYS

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -1.49M8.56M42.14M45.30M70.30M83.84M91.11M88.20M96.04M97.80M
Cost of Revenue 0.22M2.87M2.42M6.01M6.68M4.95M5.03M7.17M4.26M
Gross Profit 8.33M39.27M42.88M64.29M77.16M86.17M83.17M88.88M93.54M
Operating items
Research & Development 6.20M6.59M6.08M9.01M9.31M10.89M11.52M10.74M12.29M12.14M10.63M11.37M10.96M15.58M13.51M13.52M14.26M14.41M14.59M
Selling, General & Administrative 8.15M9.80M9.57M12.87M15.91M17.86M19.93M24.03M24.04M25.90M23.70M24.76M26.06M27.63M28.67M31.35M32.72M35.16M37.58M
Restructuring Costs 25.00M12.50M12.50M12.50M12.50M
Other Operating Expenses 100.00M2.87M2.42M6.01M6.68M4.95M5.03M7.17M4.26M
Operating Expenses 14.35M16.39M15.65M21.88M50.22M28.75M31.45M34.77M48.82M38.05M34.55M39.01M51.93M61.72M61.37M49.82M52.01M56.73M56.43M
Operating Income -14.35M-16.39M-15.65M-21.88M-50.22M-28.75M-31.45M-34.77M-48.82M-38.05M-25.99M3.14M-6.68M8.57M22.47M41.32M36.18M39.31M41.37M
EBIT -14.35M-16.39M-15.65M-21.88M-50.22M-28.75M-31.45M-34.77M-48.82M-38.05M-25.99M3.14M-6.68M8.57M22.47M41.32M36.18M39.31M41.37M
Non-operating items
Interest & Investment Income 0.03M0.03M0.06M0.07M0.26M0.65M1.60M2.72M3.53M4.84M6.74M7.52M7.62M7.48M7.30M7.29M7.42M7.47M6.59M
Net income details
EBT -15.81M-16.36M-15.59M-21.81M-49.97M-28.11M-29.85M-32.05M-45.30M-45.30M80.75M10.66M0.93M16.05M29.77M48.61M43.60M46.77M47.97M
Tax Provisions 1.97M0.48M2.60M3.10M7.90M8.44M-31.40M
Profit After Tax -15.81M-16.36M-15.59M-21.81M-49.97M-28.11M-29.85M-32.05M-45.30M-33.21M80.75M8.69M0.93M15.57M27.18M45.48M35.73M38.33M79.36M
Income from Continuing Operations -15.81M-16.36M-15.59M-21.81M-49.97M-28.11M-29.85M-32.05M-45.30M-45.30M80.75M8.69M0.93M15.57M27.17M45.51M35.70M38.33M79.37M
Consolidated Net Income -15.81M-16.36M-15.59M-21.81M-49.97M-28.11M-29.85M-32.05M-45.30M-45.30M80.75M8.69M0.93M15.57M27.17M45.51M35.70M38.33M79.37M
Income towards Parent Company -15.81M-16.36M-15.59M-21.81M-49.97M-28.11M-29.85M-32.05M-45.30M-45.30M80.75M8.69M0.93M15.57M27.17M45.51M35.70M38.33M79.37M
Net Income towards Common Stockholders -15.81M-16.36M-15.59M-21.81M-49.97M-28.11M-29.85M-32.05M-45.30M-45.30M80.75M8.69M0.93M15.57M27.17M45.51M35.70M38.33M79.37M
Additional items
EPS (Basic) -0.74-0.74-0.70-0.95-1.99-1.10-1.17-1.25-1.76-1.252.880.320.030.540.951.591.241.332.74
EPS (Weighted Average and Diluted) -0.74-0.74-0.70-0.95-1.99-1.10-1.17-1.25-1.76-1.252.790.310.030.530.911.531.201.292.66
Shares Outstanding (Weighted Average) 22.19M22.20M22.21M22.24M25.21M25.64M25.66M25.75M25.76M25.80M27.99M28.29M28.29M28.56M28.73M28.76M28.81M28.90M28.94M
Shares Outstanding (Diluted Average) 21.25M22.20M22.21M22.20M25.11M25.55M25.62M25.49M25.71M26.66M28.89M27.75M29.29M29.64M29.90M29.74M29.87M29.82M29.83M
EBITDA -15.81M-16.39M-15.58M-21.95M-51.00M-28.46M-29.78M-31.30M-44.72M-33.29M80.60M9.71M-0.01M15.23M29.33M43.78M36.31M39.10M79.31M
Interest Expenses 1.49M
Tax Rate 18.44%2.97%8.73%6.37%18.12%18.05%